Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Diagnostic Radioisotopes Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Diagnostic Radioisotopes Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Diagnostic Radioisotopes Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Diagnostic Radioisotopes Market Size Growth Rate by Type
    • 1.4.2 Tc-99m
    • 1.4.3 F-18
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Diagnostic Radioisotopes Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Cardiology
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Diagnostic Radioisotopes Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Diagnostic Radioisotopes Industry
      • 1.6.1.1 Diagnostic Radioisotopes Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Diagnostic Radioisotopes Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Diagnostic Radioisotopes Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Diagnostic Radioisotopes Market Size Estimates and Forecasts
    • 2.1.1 Global Diagnostic Radioisotopes Revenue 2015-2026
    • 2.1.2 Global Diagnostic Radioisotopes Sales 2015-2026
  • 2.2 Diagnostic Radioisotopes Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Diagnostic Radioisotopes Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Diagnostic Radioisotopes Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Diagnostic Radioisotopes Competitor Landscape by Players

  • 3.1 Diagnostic Radioisotopes Sales by Manufacturers
    • 3.1.1 Diagnostic Radioisotopes Sales by Manufacturers (2015-2020)
    • 3.1.2 Diagnostic Radioisotopes Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Diagnostic Radioisotopes Revenue by Manufacturers
    • 3.2.1 Diagnostic Radioisotopes Revenue by Manufacturers (2015-2020)
    • 3.2.2 Diagnostic Radioisotopes Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Diagnostic Radioisotopes Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Diagnostic Radioisotopes Revenue in 2019
    • 3.2.5 Global Diagnostic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Diagnostic Radioisotopes Price by Manufacturers
  • 3.4 Diagnostic Radioisotopes Manufacturing Base Distribution, Product Types
    • 3.4.1 Diagnostic Radioisotopes Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Diagnostic Radioisotopes Product Type
    • 3.4.3 Date of International Manufacturers Enter into Diagnostic Radioisotopes Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Diagnostic Radioisotopes Market Size by Type (2015-2020)
    • 4.1.1 Global Diagnostic Radioisotopes Sales by Type (2015-2020)
    • 4.1.2 Global Diagnostic Radioisotopes Revenue by Type (2015-2020)
    • 4.1.3 Diagnostic Radioisotopes Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Diagnostic Radioisotopes Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Diagnostic Radioisotopes Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Diagnostic Radioisotopes Revenue Forecast by Type (2021-2026)
    • 4.2.3 Diagnostic Radioisotopes Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Diagnostic Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Diagnostic Radioisotopes Market Size by Application (2015-2020)
    • 5.1.1 Global Diagnostic Radioisotopes Sales by Application (2015-2020)
    • 5.1.2 Global Diagnostic Radioisotopes Revenue by Application (2015-2020)
    • 5.1.3 Diagnostic Radioisotopes Price by Application (2015-2020)
  • 5.2 Diagnostic Radioisotopes Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Diagnostic Radioisotopes Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Diagnostic Radioisotopes Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Diagnostic Radioisotopes Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Diagnostic Radioisotopes by Country
    • 6.1.1 North America Diagnostic Radioisotopes Sales by Country
    • 6.1.2 North America Diagnostic Radioisotopes Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Diagnostic Radioisotopes Market Facts & Figures by Type
  • 6.3 North America Diagnostic Radioisotopes Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Diagnostic Radioisotopes by Country
    • 7.1.1 Europe Diagnostic Radioisotopes Sales by Country
    • 7.1.2 Europe Diagnostic Radioisotopes Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Diagnostic Radioisotopes Market Facts & Figures by Type
  • 7.3 Europe Diagnostic Radioisotopes Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Diagnostic Radioisotopes by Region
    • 8.1.1 Asia Pacific Diagnostic Radioisotopes Sales by Region
    • 8.1.2 Asia Pacific Diagnostic Radioisotopes Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Diagnostic Radioisotopes Market Facts & Figures by Type
  • 8.3 Asia Pacific Diagnostic Radioisotopes Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Diagnostic Radioisotopes by Country
    • 9.1.1 Latin America Diagnostic Radioisotopes Sales by Country
    • 9.1.2 Latin America Diagnostic Radioisotopes Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Diagnostic Radioisotopes Market Facts & Figures by Type
  • 9.3 Central & South America Diagnostic Radioisotopes Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Diagnostic Radioisotopes by Country
    • 10.1.1 Middle East and Africa Diagnostic Radioisotopes Sales by Country
    • 10.1.2 Middle East and Africa Diagnostic Radioisotopes Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Diagnostic Radioisotopes Market Facts & Figures by Type
  • 10.3 Middle East and Africa Diagnostic Radioisotopes Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bracco Imaging
    • 11.1.1 Bracco Imaging Corporation Information
    • 11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bracco Imaging Diagnostic Radioisotopes Products Offered
    • 11.1.5 Bracco Imaging Recent Development
  • 11.2 Bayer
    • 11.2.1 Bayer Corporation Information
    • 11.2.2 Bayer Description, Business Overview and Total Revenue
    • 11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bayer Diagnostic Radioisotopes Products Offered
    • 11.2.5 Bayer Recent Development
  • 11.3 Curium Pharmaceuticals
    • 11.3.1 Curium Pharmaceuticals Corporation Information
    • 11.3.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.3.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Curium Pharmaceuticals Diagnostic Radioisotopes Products Offered
    • 11.3.5 Curium Pharmaceuticals Recent Development
  • 11.4 Nordion
    • 11.4.1 Nordion Corporation Information
    • 11.4.2 Nordion Description, Business Overview and Total Revenue
    • 11.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Nordion Diagnostic Radioisotopes Products Offered
    • 11.4.5 Nordion Recent Development
  • 11.5 Triad Isotopes
    • 11.5.1 Triad Isotopes Corporation Information
    • 11.5.2 Triad Isotopes Description, Business Overview and Total Revenue
    • 11.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Triad Isotopes Diagnostic Radioisotopes Products Offered
    • 11.5.5 Triad Isotopes Recent Development
  • 11.6 Lantheus
    • 11.6.1 Lantheus Corporation Information
    • 11.6.2 Lantheus Description, Business Overview and Total Revenue
    • 11.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Lantheus Diagnostic Radioisotopes Products Offered
    • 11.6.5 Lantheus Recent Development
  • 11.7 GE Healthcare
    • 11.7.1 GE Healthcare Corporation Information
    • 11.7.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.7.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 GE Healthcare Diagnostic Radioisotopes Products Offered
    • 11.7.5 GE Healthcare Recent Development
  • 11.8 China Isotope & Radiation
    • 11.8.1 China Isotope & Radiation Corporation Information
    • 11.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
    • 11.8.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 China Isotope & Radiation Diagnostic Radioisotopes Products Offered
    • 11.8.5 China Isotope & Radiation Recent Development
  • 11.9 Jubilant Pharma
    • 11.9.1 Jubilant Pharma Corporation Information
    • 11.9.2 Jubilant Pharma Description, Business Overview and Total Revenue
    • 11.9.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Jubilant Pharma Diagnostic Radioisotopes Products Offered
    • 11.9.5 Jubilant Pharma Recent Development
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Corporation Information
    • 11.10.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Eli Lilly Diagnostic Radioisotopes Products Offered
    • 11.10.5 Eli Lilly Recent Development
  • 11.1 Bracco Imaging
    • 11.1.1 Bracco Imaging Corporation Information
    • 11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bracco Imaging Diagnostic Radioisotopes Products Offered
    • 11.1.5 Bracco Imaging Recent Development
  • 11.12 SIEMENS
    • 11.12.1 SIEMENS Corporation Information
    • 11.12.2 SIEMENS Description, Business Overview and Total Revenue
    • 11.12.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 SIEMENS Products Offered
    • 11.12.5 SIEMENS Recent Development
  • 11.13 Dongcheng
    • 11.13.1 Dongcheng Corporation Information
    • 11.13.2 Dongcheng Description, Business Overview and Total Revenue
    • 11.13.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Dongcheng Products Offered
    • 11.13.5 Dongcheng Recent Development
  • 11.14 Navidea
    • 11.14.1 Navidea Corporation Information
    • 11.14.2 Navidea Description, Business Overview and Total Revenue
    • 11.14.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Navidea Products Offered
    • 11.14.5 Navidea Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Diagnostic Radioisotopes Market Estimates and Projections by Region
    • 12.1.1 Global Diagnostic Radioisotopes Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Diagnostic Radioisotopes Revenue Forecast by Regions 2021-2026
  • 12.2 North America Diagnostic Radioisotopes Market Size Forecast (2021-2026)
    • 12.2.1 North America: Diagnostic Radioisotopes Sales Forecast (2021-2026)
    • 12.2.2 North America: Diagnostic Radioisotopes Revenue Forecast (2021-2026)
    • 12.2.3 North America: Diagnostic Radioisotopes Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Diagnostic Radioisotopes Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Diagnostic Radioisotopes Sales Forecast (2021-2026)
    • 12.3.2 Europe: Diagnostic Radioisotopes Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Diagnostic Radioisotopes Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Diagnostic Radioisotopes Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Diagnostic Radioisotopes Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Diagnostic Radioisotopes Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Diagnostic Radioisotopes Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Diagnostic Radioisotopes Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Diagnostic Radioisotopes Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Diagnostic Radioisotopes Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Diagnostic Radioisotopes Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Diagnostic Radioisotopes Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Diagnostic Radioisotopes Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Diagnostic Radioisotopes Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Diagnostic Radioisotopes Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Diagnostic Radioisotopes Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Diagnostic Radioisotopes Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Diagnostic Radioisotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Diagnostic Radioisotopes market is segmented into
    Tc-99m
    F-18
    Other

    Segment by Application, the Diagnostic Radioisotopes market is segmented into
    Oncology
    Cardiology
    Other

    Regional and Country-level Analysis
    The Diagnostic Radioisotopes market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Diagnostic Radioisotopes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Diagnostic Radioisotopes Market Share Analysis
    Diagnostic Radioisotopes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diagnostic Radioisotopes business, the date to enter into the Diagnostic Radioisotopes market, Diagnostic Radioisotopes product introduction, recent developments, etc.
    The major vendors covered:
    Bracco Imaging
    Bayer
    Curium Pharmaceuticals
    Nordion
    Triad Isotopes
    Lantheus
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Novartis
    SIEMENS
    Dongcheng
    Navidea

    Buy now